Stockreport

enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]

enVVeno Medical Corporation  (NVNO) 
PDF - Positive 11-month topline efficacy data presented at the 46 th Annual Charing Cross Symposium - Company on track to file PMA Application seeking VenoValve® FDA appr [Read more]